Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo

AIM: Protein kinase B (AKT) signaling frequently is deregulated in human cancers and plays an important role in nasopharyngeal carcinoma (NPC). This preclinical study investigated the effect of MK-2206, a potent allosteric AKT inhibitor, on human NPC cells in vitro and in vivo. METHODS: The effect o...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhao, Yuan-Yuan, Tian, Ying, Zhang, Jing, Xu, Fei, Yang, Yun-Peng, Huang, Yan, Zhao, Hong-Yun, Zhang, Jian-Wei, Xue, Cong, Lam, Michael H, Yan, Li, Hu, Zhi-Huang, Dinglin, Xiao-Xiao, Zhang, Li
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199975/
https://ncbi.nlm.nih.gov/pubmed/25336925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S67961
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky